For a panel of seven NSCLC lines (H2935, H1650, HCC4006, H1975, H3255, HCC827, and H820) where direct comparisons were performed, the average Ab binding capacity of the bivalent c-MET Ab was 76.3 ± 6.2% of the Ab binding capacity of the monovalent c-MET (Fig. 4B). The gene discussed is MET; the disease is non-small cell lung carcinoma.